591 related articles for article (PubMed ID: 8688321)
41. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
42. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.
Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
Tumour Biol; 2009; 30(5-6):300-9. PubMed ID: 19940551
[TBL] [Abstract][Full Text] [Related]
43. Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro.
Vink J; Thomas L; Etoh T; Bruijn JA; Mihm MC; Gattoni-Celli S; Byers HR
Lab Invest; 1993 Feb; 68(2):192-203. PubMed ID: 7680081
[TBL] [Abstract][Full Text] [Related]
44. Metastatic potential of four human melanoma xenografts in young athymic mice following tail vein inoculation.
Zimmerman RJ; Gaillard ET; Goldin A
Cancer Res; 1987 May; 47(9):2305-10. PubMed ID: 3567924
[TBL] [Abstract][Full Text] [Related]
45. Comparison of migration and invasiveness of epithelial tumor and melanoma cells in vitro.
Wach F; Eyrich AM; Wustrow T; Krieg T; Hein R
J Dermatol Sci; 1996 Jun; 12(2):118-26. PubMed ID: 8814543
[TBL] [Abstract][Full Text] [Related]
46. A tumor-associated antigen expressed in melanoma cells with lower malignant potential.
Suter L; Brüggen J; Bröcker EB; Sorg C
Int J Cancer; 1985 Jun; 35(6):787-91. PubMed ID: 3891640
[TBL] [Abstract][Full Text] [Related]
47. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
Herlyn M; Balaban G; Bennicelli J; Guerry D; Halaban R; Herlyn D; Elder DE; Maul GG; Steplewski Z; Nowell PC
J Natl Cancer Inst; 1985 Feb; 74(2):283-9. PubMed ID: 3856042
[TBL] [Abstract][Full Text] [Related]
48. Selective growth of human melanoma cells in the brain parenchyma of nude mice.
Fujimaki T; Price JE; Fan D; Bucana CD; Itoh K; Kirino T; Fidler IJ
Melanoma Res; 1996 Oct; 6(5):363-71. PubMed ID: 8908596
[TBL] [Abstract][Full Text] [Related]
49. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
50. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice.
Cornil I; Man S; Fernandez B; Kerbel RS
J Natl Cancer Inst; 1989 Jun; 81(12):938-44. PubMed ID: 2733038
[TBL] [Abstract][Full Text] [Related]
51. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
Aubert C; Rougé F; Galindo JR
J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
[TBL] [Abstract][Full Text] [Related]
52. Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures.
Hofbauer GF; Geertsen R; Laine E; Burg G; Dummer R
Melanoma Res; 2001 Jun; 11(3):213-8. PubMed ID: 11468509
[TBL] [Abstract][Full Text] [Related]
53. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse.
Hayashi H; Shimizu R; Fujii K; Itoh S; Yang D; Onozaki K
Int J Cancer; 1997 May; 71(3):416-21. PubMed ID: 9139878
[TBL] [Abstract][Full Text] [Related]
54. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.
Miller AR; McBride WH; Dubinett SM; Dougherty GJ; Thacker JD; Shau H; Kohn DB; Moen RC; Walker MJ; Chiu R
Blood; 1993 Dec; 82(12):3686-94. PubMed ID: 8260705
[TBL] [Abstract][Full Text] [Related]
55. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
[TBL] [Abstract][Full Text] [Related]
56. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
57. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
58. Regional growth of different human melanomas as metastases in the brain of nude mice.
Schackert G; Price JE; Zhang RD; Bucana CD; Itoh K; Fidler IJ
Am J Pathol; 1990 Jan; 136(1):95-102. PubMed ID: 2297053
[TBL] [Abstract][Full Text] [Related]
59. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
[TBL] [Abstract][Full Text] [Related]
60. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
